bioRxivNeurosciencePreprint
Mitochondrial dysfunction Impairs the Nuclear Pore Complex in Parkinson's Disease Pathogenesis
Zainab RiaziD, Yuan-Teng Chang, Gary D. ZenitskyiD, Huajun JiniD, Vellareddy AnantharamiD, Arthi KanthasamyiD, Anumantha Kanthasamy
Abstract
The mislocalization of transcription factors and irregularities in the nuclear envelope of dopaminergic neurons affected by Parkinsons disease (PD) implicates the nuclear pore in disease pathogenesis. While mitochondrial dysfunction is an integral component of PD pathophysiology, the involvement of channel-forming nucleoporins (Nups) in mitochondrial dysfunction-related neurodegeneration has not been investigated. Here we have identified pathological changes in the levels and distribution of a set of Nups, which are key structural and functional components of the nuclear pore complex, in dopaminergic neuronal models of PD. We observed that mitochondrial dysfunction reduces the expression of these Nups and disrupts the localization of Ran GTPase in both in vitro and in vivo dopaminergic neuron models. Furthermore, the nuclear pore central channel component, Nup62, mislocalizes and accumulates in the cytoplasm of these neurons under mitochondrial stress conditions. Mitochondrial stress also interferes with classical nuclear export of proteins in dopaminergic neural cells. Notably, we observed Nup pathology and Ran gradient loss in nigral dopaminergic neurons of PD patient brains, which highlights the clinical relevance of nuclear pore dysfunction as a disease mechanism. These findings provide direct evidence of the critical role of Nup-related abnormalities in mitochondrial dysfunction-induced degeneration of dopaminergic neurons, ultimately connecting nuclear pore complex and nucleocytoplasmic transport dysregulation to cell death in the development of PD. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=158 HEIGHT=200 SRC="FIGDIR/small/622143v1_ufig1.gif" ALT="Figure 1"> View larger version (37K): org.highwire.dtl.DTLVardef@193d8acorg.highwire.dtl.DTLVardef@176135forg.highwire.dtl.DTLVardef@f1edceorg.highwire.dtl.DTLVardef@1338d9d_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: proteomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: protein structure prediction
- approach: statistical model
- approach: experimental assay
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mitochondrial fitness influences neuronal excitability of dopaminergic neurons from patients with idiopathic form of Parkinson's disease
Paula Chlebanowska, Agata Szlaga, … Marcin Majka·bioRxiv·Apr 28, 2023
- Parkinson's disease-related Miro1 mutation induces mitochondrial dysfunction and loss of dopaminergic neurons in vitro and in vivo
Axel Chemla, Giuseppe Arena, … Cláudia Saraiva·BrainPeer-reviewed·Feb 5, 2025
- Imbalanced mitochondrial dynamics in human and mouse PD brains
Harry J. Brown, Rebecca Zhangqiuzi Fan, … Kim Tieu·bioRxiv·Jan 27, 2025
- Genetic modulation of mitochondrial NAD+ regeneration does not prevent dopaminergic neuron dysfunction caused by mitochondrial complex I impairment
Karis B. D’Alessandro, Enrico Zampese, … Navdeep S. Chandel·Frontiers in Cell and Developmental BiologyPeer-reviewed·Sep 25, 2025
- Defects in Mitochondrial Biogenesis Drive Mitochondrial Alterations in PINK1-deficient Human Dopamine Neurons
Hu Wang, Rong Chen, … Ted M. Dawson·bioRxiv·Jun 23, 2023
- The UPRER governs the cell-specific response of human dopaminergic neurons to mitochondrial stress
Jana Heneine, Claire Sauty-Colace, … Hélène Cheval·bioRxiv·Jun 17, 2024